Last reviewed · How we verify
Collection of biological parameters
At a glance
| Generic name | Collection of biological parameters |
|---|---|
| Also known as | Biological draws (blood and salivary) |
| Sponsor | Istituto Auxologico Italiano |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms (PHASE2)
- Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation (PHASE2)
- Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel (PHASE1)
- Perioperative Sepsis. An Epigenetic Perspective
- Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases (NA)
- Venous Congestion and Organ Dysfunction.
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Collection of biological parameters CI brief — competitive landscape report
- Collection of biological parameters updates RSS · CI watch RSS
- Istituto Auxologico Italiano portfolio CI